In fact, just recently I think in the last two or three weeks Johnson & Johnson did a deal with a US listed company, Arrowhead, for their Hepatitis B programme which was in phase 1/2A and I think that that was quite a significant deal, I don’t have the numbers straight in front of me but it was in the order of maybe $1.7 billion or more for them to work together on that. There’s quite a bit of money even in these early stage anti-viral programmes if you can find the right drug at the right stage and find the right partner and ideally have more than one want you, then you can get a good return for your shareholders.
$10 Billion Deal, page-84
-
- There are more pages in this discussion • 8,347 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
0.001(2.63%) |
Mkt cap ! $17.59M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 2.0¢ | 1.9¢ | $11.54K | 604.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 1466986 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 830622 | 7 |
View Market Depth
| Last trade - 15.55pm 15/11/2024 (20 minute delay) ? |
| BIT (ASX) Chart |